Latest News

Novartis's Pelacarsen Fails to Prevent Heart Attacks in Major Trial Despite Lowering Lp(a)
Health

Novartis's Pelacarsen Fails to Prevent Heart Attacks in Major Trial Despite Lowering Lp(a)

Novartis's experimental heart drug pelacarsen, widely anticipated to reduce heart attacks and strokes, has failed a large seven-year clinical trial. Despite significantly lowering lipoprotein(a) levels, the drug showed no benefit over placebo in preventing major cardiovascular events or deaths, disappointing cardiologists and raising questions about the direct causal link between Lp(a) and heart disease.

UK Air Traffic Control Failure Deemed Avoidable Amidst Widespread Chaos
Business

UK Air Traffic Control Failure Deemed Avoidable Amidst Widespread Chaos

A major technical failure in the UK's air traffic control system, operated by NATS, has been declared avoidable by the Transport Secretary. The incident caused over 2,000 flight cancellations, stranding passengers for days. An independent investigation has been launched, raising questions about NATS' system resilience and consumer redress.

Everton's Transfer Window Woes: Squad Gaps and Financial Strain
Sports

Everton's Transfer Window Woes: Squad Gaps and Financial Strain

Everton's recent transfer window appears to have left the squad with critical weaknesses, raising concerns about financial stability and on-field performance. An analysis of their moves reveals a pattern of missed opportunities and potential long-term repercussions.